2m 2m 2m 2m 2m 2m 2m
Innov Medtech (IMTH)
OTC
$0.002+$0.0003 (+25.00%)
Price as of Jun 02, 2026- $84,783.00Market Cap
- -99.29%1-Year Change
- Software - InfrastructureIndustry
Innov Medtech (IMTH)
$0.002+$0.0003 (+25.00%)
Annual
Quarterly
06/30/2025 | 06/30/2024 | 06/30/2023 | 06/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 1.8M +5.80% | 1.7M +32.92% | 1.3M +271.66% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 -100.00% | 1.8M +5.80% | 1.7M +32.92% | 1.3M +271.66% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | N/A N/A | 62,147 +10.11% | 56,440 -18.17% | 68,969 +615.59% | |
Total Operating Expenses | 2.7M -55.26% | 6.1M +14.02% | 5.3M -72.65% | 19.6M +1,748.33% | |
Operating Profit | -2.7M -36.15% | -4.3M +17.93% | -3.6M -80.15% | -18.3M +2,475.64% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -84,905 -40.70% | -143,186 -7.62% | -155,005 -15.07% | -182,500 +5.93% | |
Interest Income and Expense and Net | -84,905 -40.70% | -143,186 -7.62% | -155,005 -15.07% | -182,500 +5.93% | |
Total Nonoperating Income and Expense | 540,262 +114.74% | -3.7M -2,464.32% | 155,005 -15.07% | 182,500 +5.93% | |
Income before Taxes | 1.3M +129.69% | -4.3M +17.93% | -3.6M -80.15% | -18.3M +2,475.64% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 1.3M +115.98% | -7.9M +117.63% | -3.6M -79.80% | -18.1M +453.10% | |
Net Income from Continuing Operations Applicable to Common | -2.2M -72.43% | -7.9M +117.63% | -3.6M -79.80% | -18.1M +453.10% | |
Basic EPS and Net Income | N/A N/A | -0.33 +94.12% | -0.17 -84.40% | -1.09 -29.22% | |
Diluted EPS and Net Income | 0.03 +109.09% | -0.33 +94.12% | -0.17 -84.40% | -1.09 -29.22% | |
Basic Weighted Average Shares | 40.9M +71.34% | 23.9M +12.80% | 21.2M +27.42% | 16.6M +684.26% | |
Diluted Weighted Average Shares | 40.9M +71.34% | 23.9M +12.80% | 21.2M +27.42% | 16.6M +684.26% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 13,616 -88.00% | 113,489 -27.98% | 157,589 -47.70% | 301,337 -30.48% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 13,616 -88.00% | 113,489 -27.98% | 157,589 -47.70% | 301,337 -30.48% | |
Total Current Assets | 22,910 -91.93% | 283,779 -27.93% | 393,774 -23.53% | 514,911 -23.96% | |
Accumulated Depreciation | 59,296 +0.002% | 59,295 -19.65% | 73,792 +50.91% | 48,898 +407.35% | |
Property and Plant and Equipment and Net | 107,455 -0.0009% | 107,456 -65.11% | 307,997 -7.48% | 332,891 +2.18% | |
Total Long-Term Assets | 107,455 -0.0009% | 107,456 -65.11% | 307,997 -7.48% | 332,891 N/A | |
Total Assets | 250,410 -61.59% | 651,881 -85.35% | 4.4M -7.30% | 4.8M -8.46% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 330,871 -49.66% | 657,256 +43.83% | 456,969 -49.96% | 913,188 -14.26% | |
Total Current Liabilities | 1.3M -68.27% | 4.1M +14.89% | 3.6M -7.18% | 3.9M +37.97% | |
Total Long-Term Debt | 342,221 +469.91% | 60,048 -83.63% | 366,720 -69.89% | 1.2M +6.55% | |
Total Long-Term Liabilities | 62,733 -60.28% | 157,934 -43.72% | 280,637 -30.75% | 405,235 -48.92% | |
Total Liabilities | 1.3M -78.75% | 6.1M +6.55% | 5.8M -7.29% | 6.2M +17.19% | |
Retained Earnings | -43.3M -2.85% | -44.6M +21.68% | -36.6M +11.06% | -33.0M +121.07% | |
Total Stockholders Equity | -1.1M -80.79% | -5.5M +319.06% | -1.3M -7.24% | -1.4M +2,443.85% | |
Total Shares Outstanding | 59.8M +150.56% | 23.9M +12.88% | 21.2M 0.00% | 21.2M +36.00% | |
Cash Flow | |||||
Cash from Operating Activities | 1.5M +915.38% | -183,131 +8.38% | -168,972 -71.01% | -582,878 -2,174.30% | |
Capital Expenditures | N/A N/A | 50,673 +302.42% | 12,592 N/A | N/A N/A | |
Cash from Investing Activities | -127,500 +151.61% | -50,673 -1,037.87% | 5,403 +152.98% | -10,199 -99.35% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -1.4M -813.20% | 189,704 +857.09% | 19,821 -95.70% | 460,979 -76.56% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | -234.21% +11.46% | -210.12% -85.07% | -1,407.05% N/A | |
Return on Assets | 281.26% +190.37% | -311.24% +294.59% | -78.88% -78.06% | -359.59% N/A | |
Return on Equity | -38.83% -116.61% | 233.79% -12.88% | 268.35% -89.11% | 2,463.82% N/A | |
Revenue Growth | N/A N/A | 5.80% -82.38% | 32.92% -87.88% | 271.66% N/A | |
Current Ratio | 0.02 -74.53% | 0.07 -37.24% | 0.11 -17.65% | 0.13 N/A | |
Cash Ratio | 0.01 -62.32% | 0.03 -37.41% | 0.04 -43.61% | 0.08 N/A | |
Debt-to-Equity Ratio | -0.64 +388.69% | -0.13 -79.22% | -0.63 -58.34% | -1.51 N/A | |
Debt-to-Assets Ratio | 2.69 +144.27% | 1.10 +494.49% | 0.19 -58.31% | 0.44 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow